{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:47:09Z","timestamp":1768034829195,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Walloon Region","award":["N\u00b07245"],"award-info":[{"award-number":["N\u00b07245"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/toxsci\/kfy204","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T19:18:57Z","timestamp":1534965537000},"page":"441-450","source":"Crossref","is-referenced-by-count":10,"title":["Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury"],"prefix":"10.1093","volume":"166","author":[{"given":"Jana","family":"Obajdin","sequence":"first","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"},{"name":"Centre for Stem Cells & Regenerative Medicine King\u2019s College London, Tower Wing Guy\u2019s Campus Great Maze Pond London SE1 9RT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabel","family":"Cotter","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"},{"name":"Safety & Environmental Assurance Centre, Unilever U.K., Unilever House, Blackfriars, London EC4Y 0DY, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Snelling","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"},{"name":"Immunology, Abzena, Babraham Research Campus, Cambridge CB22 3AT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Dremier","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"},{"name":"Ogeda SA, 47 Rue Adrienne Bolland, Gosselies, Belgium 6041, Sarah Dremier"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierrette","family":"De Ron","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Fleurance","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Valentin","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Nogueira da Costa","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Experimental Medicine and Diagnostics, UCB Biopharma SPRL, Chemin du Foriest 1, B-1420 Braine L'Alleud, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitalina","family":"Gryshkova","sequence":"additional","affiliation":[{"name":"Department of Development Science, Investigative Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0192623311436174","article-title":"Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic acid","volume":"40","author":"Betton","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B2","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Board","year":"2013","journal-title":"Kidney Int. Suppl"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B4","first-page":"432","volume-title":"Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers","author":"Chen","year":"2016"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B7","doi-asserted-by":"crossref","first-page":"188.","DOI":"10.1186\/s13054-016-1353-y","article-title":"Acute kidney injury: Short-term and long-term effects","volume":"20","author":"Doyle","year":"2016","journal-title":"Crit. Care"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.numecd.2014.03.006","article-title":"Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction","volume":"24","author":"Ebert","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0192623314554840","article-title":"Recent successes in the identification, development, and qualification of translational biomarkers: The next generation of kidney injury biomarkers","volume":"43","author":"Ennulat","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/0192623312444618","article-title":"Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials","volume":"40","author":"Fuchs","year":"2012","journal-title":"Toxicol. Pathol."},{"issue":"Suppl 3","key":"key\n\t\t\t\t2018112810552637700_kfy204-B11","first-page":"23","article-title":"Fatty acid-binding protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"8","author":"Furuhashi","year":"2014","journal-title":"Clini. Med. Insights Cardiol"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B12","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Ghane Shahrbaf","year":"2015","journal-title":"J. Renal Inj. Prev."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B13","doi-asserted-by":"crossref","first-page":"e5146.","DOI":"10.1371\/journal.pone.0005146","article-title":"An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes","volume":"4","author":"Jia","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B14","first-page":"635","article-title":"[Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan]","volume":"61","author":"Kamijo-Ikemori","year":"2013","journal-title":"Rinsho Byori"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/00365513.2017.1355561","article-title":"Urine liver fatty acid binding protein and chronic kidney disease progression","volume":"77","author":"Khatir","year":"2017","journal-title":"Scand. J. Clin. Labor. Invest."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B17","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2014\/601568","article-title":"Acute kidney injury in neonates: From urine output to new biomarkers","volume":"2014","author":"Liborio","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj2880285","article-title":"Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction","volume":"288","author":"Maatman","year":"1992","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B19","author":"Melanie Blank","year":"2009"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B20","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.ajkd.2005.11.006","article-title":"Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy","volume":"47","author":"Nakamura","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfv167","article-title":"Identification of promising urinary MicroRNA biomarkers in two rat models of glomerular injury","volume":"148","author":"Nassirpour","year":"2015","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B23","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am. Fam. Phys."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B24","doi-asserted-by":"crossref","first-page":"iii96","DOI":"10.1093\/ndt\/gfr222","article-title":"Albuminuria increases cystatin C excretion: Implications for urinary biomarkers","volume":"27","author":"Nejat","year":"2012","journal-title":"Nephrol. Dial. Transplant"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B25","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.90513.2008","article-title":"Urinary fatty acid-binding protein 1: An early predictive biomarker of kidney injury","volume":"296","author":"Noiri","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-642-00663-0_5","article-title":"Mechanisms of drug-induced nephrotoxicity","volume":"196","author":"Nolin","year":"2010","journal-title":"Handb. Exp. Pharmacol"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B27","doi-asserted-by":"crossref","first-page":"e115429.","DOI":"10.1371\/journal.pone.0115429","article-title":"Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction","volume":"9","author":"Okazaki","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B28","doi-asserted-by":"crossref","first-page":"233.","DOI":"10.1186\/cc11380","article-title":"Clinical review: Biomarkers of acute kidney injury: Where are we now?","volume":"16","author":"Ostermann","year":"2012","journal-title":"Critical Care"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2014.10.121","article-title":"Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse","volume":"454","author":"Ozawa","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B30","first-page":"457","article-title":"Drug-induced impairment of renal function","volume":"7","author":"Pazhayattil","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B31","author":"SAFE-T Consortium","year":"2017"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bcp.12198","article-title":"Measurement of renal function in patients with chronic kidney disease","volume":"76","author":"Sandilands","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B33","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1016\/S0021-9258(19)57250-7","article-title":"The nucleotide sequence of the rat liver fatty acid-binding protein gene. Evidence that exon 1 encodes an oligopeptide domain shared by a family of proteins which bind hydrophobic ligands","volume":"261","author":"Sweetser","year":"1986","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000368412","article-title":"Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction","volume":"128","author":"Tanaka","year":"2015","journal-title":"Nephron Clin. Pract."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B35","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1155\/2013\/361078","article-title":"Role of new biomarkers: Functional and structural damage","volume":"2013","author":"Tsigou","year":"2013","journal-title":"Crit. Care Res. Pract."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bcp.12282","article-title":"Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development","volume":"77","author":"van Meer","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/0192623312444765","article-title":"Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats","volume":"40","author":"Vinken","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B38","doi-asserted-by":"crossref","first-page":"c192","DOI":"10.1159\/000142928","article-title":"Biomarkers for the diagnosis of acute kidney injury","volume":"109","author":"Waikar","year":"2008","journal-title":"Nephron Clin. Pract."},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/13547500310001647030","article-title":"1H-Nuclear magnetic resonance pattern recognition studies with N-phenylanthranilic acid in the rat: Time- and dose-related metabolic effects","volume":"8","author":"Williams","year":"2003","journal-title":"Biomarkers"},{"key":"key\n\t\t\t\t2018112810552637700_kfy204-B40","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1681\/ASN.2007010097","article-title":"Renal L-type fatty acid\u2013binding protein in acute ischemic injury","volume":"18","author":"Yamamoto","year":"2007","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/166\/2\/441\/26827331\/kfy204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:46:01Z","timestamp":1720532761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/166\/2\/441\/5079024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,8,24]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfy204","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,24]]}}}